SPY386.54-3.04 -0.78%
DIA314.19-1.40 -0.44%
IXIC13,358.79-230.04 -1.69%

BRIEF-India Drug Regulator Committee Does Not Recommend Emergency Use Permission For Pfizer's COVID-19 Vaccine

· 02/05/2021 04:01
BRIEF-India Drug Regulator Committee Does Not Recommend Emergency Use Permission For Pfizer's COVID-19 Vaccine

- Central Drugs Standard Control Organization Subject Expert Committee:

  • INDIA DRUG REGULATOR COMMITTEE SAYS NOT RECOMMENDED GRANTING PERMISSION FOR EMERGENCY USE FOR PFIZER'S COVID-19 VACCINE - STATEMENT

  • INDIA DRUG REGULATOR COMMITTEE SAYS PFIZER LTD DID NOT PROPOSE ANY PLAN TO GENERATE SAFETY & IMMUNOGENICITY DATA IN INDIAN POPULATION

  • INDIA DRUG REGULATOR COMMITTEE ON PFIZER COVID-19 VACCINE SAYS NOTED SIDE EFFECTS REPORTED ABROAD, CAUSALITY OF EVENTS BEING INVESTIGATED

Source text: (https://bit.ly/39MfJOh)

Further company coverage: PFIZ.NSPFE.N[22UAy.DE]


((Reuters.Briefs@thomsonreuters.com;))